Molecular Diagnostics Market, Global Forecast by Application, Technology, End User, Regions, Companies

July 2018 | | ID: M77014F74A5EN
Renub Research

Abstracts

Global Molecular Diagnostics market is projected to become US$ 20.5 Billion opportunities by the year 2024, owing a significant growth during the forecast period. Some of the key factors that can be attributed to the growth of the molecular diagnostics market include rising prevalence of diseases, including cancers, growing awareness and acceptance of companion & personalized diagnostics and advancement in the molecular diagnostics techniques. Furthermore; rising incidence of neurological, cardiovascular and genetic disorders also helps molecular diagnostics market thrive in the coming years.

It is believed that development in molecular diagnostics has facilitated early detection of various diseases which possibly could result in major socioeconomic burden. According to WHO; the average prevalence of health care-associated infection varies between 3.5% and 12% in developed countries. While, the European Centre for Disease Prevention and Control reports an average prevalence of 7.1% in European countries. Molecular diagnostics plays a significant role in the diagnosis of infectious diseases as they provide effective results in no time.

Renub Research report titled “Molecular Diagnostics Market, By Application (Infectious Diseases, Blood Screening, Oncology, Genetic Testing, HLA (Tissue Typing), Microbiology, Cardiovascular Diseases, Neurological Diseases, Pharmacogenomics and Others), By Technology (PCR, Transcription-Mediated Amplification (TMA), Hybridiazation (In-situ Hybridiazation & FISH), DNA Sequencing & NGS, Microarray and Others), By End User (Hospitals & Academic Laboratories, Clinics and Commercial Laboratories, Others), By Regions [United States, Europe (Expect Russia), India, China, Japan, Brazil, South Korea, Mexico, Russia and ROW], Companies (Roche, Abbott, Myriad Genetics, Qiagen, BioMerieux and Others)” provides a complete analysis of Molecular Diagnostics Market.

By Application – Infectious Disease Testing holds the Maximum Market Share

The report studies the market of the following Diagnostics segments: Infectious Diseases, Blood Screening, Oncology, Genetic Testing, HLA (Tissue Typing), Microbiology, Cardiovascular Diseases, Neurological Diseases, Pharmacogenomics and Others.

By Technology – PCR Segment is leading the market and will continue so during the Forecast period

On the basis of technology, the molecular diagnostics market has been broadly segmented into PCR, Transcription-Mediated Amplification (TMA), Hybridiazation (In-situ Hybridiazation & FISH), DNA Sequencing & NGS, Microarray and Others.

By End User – Hospitals & Academic Laboratory holds the Largest Market

The report studies the market of the following End User segments: Hospitals & Academic Laboratories, Clinics & Commercial Laboratories and Others.

By Regions – United States and Europe dominates the Molecular Diagnostics Market

United States and Europe together controls the Molecular Diagnostics Market. In addition; the report also provides the complete geographical analysis India, China, Japan, Brazil, South Korea, Mexico, Russia and Rest of World Molecular Diagnostics Market.

Companies Analysis

Roche, Abbott, Myriad Genetics, Qiagen and BioMerieux are some of the top companies operating in the Molecular Diagnostics; which has been studied thoroughly in the report.

This market research report provides a complete analysis of the Molecular Diagnostics Market, Growth Drivers, Challenges, and their projections for the upcoming years.

By Application

• Infectious Diseases
• Blood Screening
• Oncology
• Genetic Testing
• HLA (Tissue Typing)
• Microbiology
• Cardiovascular Diseases
• Neurological Diseases
• Pharmacogenomics
• Others

By Technology

• PCR
• Transcription-Mediated Amplification (TMA)
• Hybridiazation (In-situ Hybridiazation & FISH)
• DNA Sequencing & NGS
• Microarray
• Others

By End User

• Hospitals & Academic Laboratories
• Clinics & Commercial Laboratories
• Others

By Regions

• United States
• Europe (Expect Russia)
• India
• China
• Japan
• Brazil
• South Korea
• Mexico
• Russia
• Rest of World

Company Analysis

• Roche
• Abbott
• Myriad Genetics
• Qiagen
• BioMerieux

Contents

1. EXECUTIVE SUMMARY

2. GLOBAL MOLECULAR DIAGNOSTIC MARKET

3. MARKET SHARE – GLOBAL MOLECULAR DIAGNOSTICS

3.1 By Application
3.2 By Technology
3.3 By Countries
3.4 By Companies

4. APPLICATION – MOLECULAR DIAGNOSTICS MARKET

4.1 Infectious Diseases
  4.1.1 Hospital Acquired Infections (HAI)
  4.1.2 HIV / HCV Testing
  4.1.3 STD Testing
  4.1.4 HPV Testing
4.2 Blood Screening
4.3 Oncology / Cancer
  4.3.1 Breast
  4.3.2 Colorectal
  4.3.3 Prostate
  4.3.4 Others
4.4 Genetic Testing
4.5 HLA (Tissue Typing)
4.6 Microbiology
4.7 Cardiovascular Diseases
4.8 Neurological Diseases
4.9 Pharmacogenomics
4.10 Others

5. TECHNOLOGY – MOLECULAR DIAGNOSTICS MARKET

5.1 PCR
5.2 Transcription-Mediated Amplification (TMA)
5.3 Hybridiazation (In-situ Hybridiazation & FISH)
5.4 DNA Sequencing & NGS
5.5 Microarray
5.6 Others

6. REGION - MOLECULAR DIAGNOSTICS MARKET

6.1 United States
6.2 Europe
6.3 India
6.4 China
6.5 Japan
6.6 Brazil
6.7 South Korea
6.8 Mexico
6.9 Russia
6.10 Rest of World (ROW)

7. END USERS - MOLECULAR DIAGNOSTICS MARKET

7.1 Hospitals & Academic Laboratories
7.2 Clinics and Commercial Laboratories
7.3 Others

8. ROCHE DIAGNOSTICS – COMPANY ANALYSIS

8.1 Merger & Acquisitions
8.2 Sales Analysis

9. ABBOTT LABORATORIES – COMPANY ANALYSIS

9.1 Merger & Acquisitions
9.2 Sales Analysis

10. MYRIAD GENETICS – COMPANY ANALYSIS

10.1 Merger & Acquisitions
10.2 Sales Analysis

11. QIAGEN – COMPANY ANALYSIS

11.1 Merger & Acquisitions
11.2 Sales Analysis

12. BIOMERIEUX’S INC – COMPANY ANALYSIS

12.1 Merger & Acquisitions
12.2 Sales Analysis

13. MARKET DRIVERS

13.1 Various Developments in the Molecular Diagnostics Landscape
13.2 Integral to Traditional Labs
13.3 Improved Assay / Test Efficiencies
13.4 Targeting Antibiotic Resistance
13.5 Next Generation Ultrasensitive Molecular Diagnostics
13.6 Increasing Investment in Genomics & Proteomics Research
13.7 Technological Advances in Molecular Diagnostics
13.8 Increasing Acceptance of the Personalized Medicine
13.9 Growing Molecular Diagnostics for Food Safety

14. CHALLENGES

14.1 Dearth of Trained Professionals
14.2 Regulatory Issues
14.3 Various Factors Slowing Growth of Molecular Diagnostics
14.4 Reimbursement Capabilities
14.5 Quality Checkpoints, Awareness & Acceptance

List Of Figures

LIST OF FIGURES

Figure 2-1: Global- Molecular Diagnostics Market (Million US$), 2011 – 2017
Figure 2-2: Global – Forecast for Molecular Diagnostics Market (Million US$), 2018 – 2024
Figure 3-1: Global- Molecular Diagnostics Market Share by Application (Percent), 2011 – 2017
Figure 3-2: Global- Forecast for Molecular Diagnostics Market Share by Application (Percent), 2018 – 2024
Figure 3-3: Global- Molecular Diagnostics Market Share by Technology (Percent), 2011 – 2017
Figure 3-4: Global- Forecast for Molecular Diagnostics Market Share by Technology (Percent), 2018 – 2024
Figure 3-5: Global- Molecular Diagnostics Market Share by Countries (Percent), 2011 – 2017
Figure 3-6: Global- Forecast for Molecular Diagnostics Market Share by Countries (Percent), 2018 – 2024
Figure 3-7: Global- Molecular Diagnostics Market Share by Companies (Percent), 2011 – 2017
Figure 3-8: Global- Forecast for Molecular Diagnostics Market Share by Companies (Percent), 2018 – 2024
Figure 4-1: Global- Molecular Diagnostics Market by Infectious Diseases (Million US$), 2011 – 2017
Figure 4-2: Global- Forecast for Molecular Diagnostics Market by Infectious Diseases (Million US$), 2018 – 2024
Figure 4-3: Global- Molecular Diagnostics Market by Hospital Acquired Infection (Million US$), 2011 – 2017
Figure 4-4: Global- Forecast for Molecular Diagnostics Market by Hospital Acquired Infection (Million US$), 2018 – 2024
Figure 4-5: Global- Molecular Diagnostics Market by HIV/HCV Testing (Million US$), 2011 – 2017
Figure 4-6: Global- Forecast for Molecular Diagnostics Market by HIV/HCV Testing (Million US$), 2018 – 2024
Figure 4-7: Global- Molecular Diagnostics Market by STD Testing (Million US$), 2011– 2017
Figure 4-8: Global- Forecast for Molecular Diagnostics Market by STD Testing (Million US$), 2018 – 2024
Figure 4-9: Global- Molecular Diagnostics Market by HPV Testing (Million US$), 2011 – 2017
Figure 4-10: Global- Forecast for Molecular Diagnostics Market by HPV Testing (Million US$), 2018 – 2024
Figure 4-11: Global- Molecular Diagnostics Market by Blood Screening (Million US$), 2010 – 2017
Figure 4-12: Global- Forecast for Molecular Diagnostics Market by Blood Screening (Million US$), 2018 – 2024
Figure 4-13: Global- Molecular Diagnostics Market by Oncology (Million US$), 2010 – 2017
Figure 4-14: Global- Forecast for Molecular Diagnostics Market by Oncology (Million US$), 2018 – 2024
Figure 4-15: Global- Molecular Diagnostics Market by Breast (Million US$), 2010 – 2017
Figure 4-16: Global- Forecast for Molecular Diagnostics Market by Breast (Million US$), 2018 – 2024
Figure 4-17: Global- Molecular Diagnostics Market by Colorectal (Million US$), 2010 – 2017
Figure 4-18: Global- Forecast for Molecular Diagnostics Market by Colorectal (Million US$), 2018 – 2024
Figure 4-19: Global- Molecular Diagnostics Market by Prostate (Million US$), 2010 – 2017
Figure 4-20: Global- Forecast for Molecular Diagnostics Market by Prostate (Million US$), 2018 – 2024
Figure 4-21: Global- Molecular Diagnostics Market by Others (Million US$), 2010 – 2017
Figure 4-22: Global- Forecast for Molecular Diagnostics Market by Others (Million US$), 2018 – 2024
Figure 4-23: Global- Molecular Diagnostics Market by Genetic Testing (Million US$), 2010 – 2017
Figure 4-24: Global- Forecast for Molecular Diagnostics Market by Genetic Testing (Million US$), 2018 – 2024
Figure 4-25: Global- Molecular Diagnostics Market by HLA (Tissue Typing) (Million US$), 2011 – 2017
Figure 4-26: Global- Forecast for Molecular Diagnostics Market by HLA (Tissue Typing) (Million US$), 2018 – 2024
Figure 4-27: Global- Molecular Diagnostics Market by Microbiology (Million US$), 2011 – 2017
Figure 4-28: Global- Forecast for Molecular Diagnostics Market by Microbiology (Million US$), 2018 – 2024
Figure 4-29: Global- Forecast for Molecular Diagnostics Market by Cardiovascular Diseases (Million US$), 2011 – 2017
Figure 4-30: Global- Forecast for Molecular Diagnostics Market by Cardiovascular Diseases (Million US$), 2018 – 2024
Figure 4-31: Global- Molecular Diagnostics Market by Neurological Diseases (Million US$), 2011 – 2017
Figure 4-32: Global- Forecast for Molecular Diagnostics Market by Neurological Diseases (Million US$), 2018 – 2024
Figure 4-33: Global- Molecular Diagnostics Market by Pharmacogenomics (Million US$), 2011 – 2017
Figure 4-34: Global- Forecast for Molecular Diagnostics Market by Pharmacogenomics (Million US$), 2018 – 2024
Figure 4-35: Global- Molecular Diagnostics Market by Others (Million US$), 2011 – 2017
Figure 4-36: Global- Forecast for Molecular Diagnostics Market by Others (Million US$), 2018 – 2024
Figure 5-1: Global- Molecular Diagnostics Market by PCR (Million US$), 2011 – 2017
Figure 5-2: Global- Forecast for Molecular Diagnostics Market by PCR (Million US$), 2018 – 2024
Figure 5-3: Global- Molecular Diagnostics Market by TMA (Million US$), 2011 – 2017
Figure 5-4: Global- Forecast for Molecular Diagnostics Market by TMA (Million US$), 2018 – 2024
Figure 5-5: Global- Molecular Diagnostics Market by Hybridiazation (Million US$), 2011 – 2017
Figure 5-6: Global- Forecast for Molecular Diagnostics Market by Hybridiazation (Million US$), 2018 – 2024
Figure 5-7: Global- Molecular Diagnostics Market by DNA Sequencing & NGS (Million US$), 2011 – 2017
Figure 5-8: Global- Forecast for Molecular Diagnostics Market by DNA Sequencing & NGS (Million US$), 2018 – 2024
Figure 5-9: Global- Molecular Diagnostics Market by Microarray (Million US$), 2011 – 2017
Figure 5-10: Global- Forecast for Molecular Diagnostics Market by Microarray (Million US$), 2018 – 2024
Figure 5-11: Global- Molecular Diagnostics Market by Others (Million US$), 2011 – 2017
Figure 5-12: Global- Forecast for Molecular Diagnostics Market by Others (Million US$), 2018 – 2024
Figure 6-1: United States - Molecular Diagnostics Market (Million US$), 2011 – 2017
Figure 6-2: United States – Forecast for Molecular Diagnostics Market (Million US$), 2018 – 2024
Figure 6-3: Europe – Molecular Diagnostics Market (Million US$), 2011 – 2017
Figure 6-4: Europe – Forecast for Molecular Diagnostics Market (Million US$), 2018 – 2024
Figure 6-5: India –Molecular Diagnostics Market (Million US$), 2011 – 2017
Figure 6-6: India – Forecast for Molecular Diagnostics Market (Million US$), 2018 – 2024
Figure 6-7: China – Molecular Diagnostics Market (Million US$), 2011 – 2017
Figure 6-8: China – Forecast for Molecular Diagnostics Market (Million US$), 2018 – 2024
Figure 6-9: Japan –Molecular Diagnostics Market (Million US$), 2011 – 2017
Figure 6-10: Japan – Forecast for Molecular Diagnostics Market (Million US$), 2018 – 2024
Figure 6-11: Brazil –Molecular Diagnostics Market (Million US$), 2011 – 2017
Figure 6-12: Brazil – Forecast for Molecular Diagnostics Market (Million US$), 2018 – 2024
Figure 6-13: South Korea –Molecular Diagnostics Market (Million US$), 2011 – 2017
Figure 6-14: South Korea – Forecast for Molecular Diagnostics Market (Million US$), 2018 – 2024
Figure 6-15: Mexico –Molecular Diagnostics Market (Million US$), 2011 – 2017
Figure 6-16: Mexico – Forecast for Molecular Diagnostics Market (Million US$), 2018 – 2024
Figure 6-17: Russia –Molecular Diagnostics Market (Million US$), 2011 – 2017
Figure 6-18: Russia – Forecast for Molecular Diagnostics Market (Million US$), 2018 – 2024
Figure 6-19: ROW –Molecular Diagnostics Market (Million US$), 2011 – 2017
Figure 6-20: ROW – Forecast for Molecular Diagnostics Market (Million US$), 2018 – 2024
Figure 7-1: Global - Molecular Diagnostics Market by Hospitals & Academic Laboratories (Million US$), 2011 – 2017
Figure 7-2: Global – Forecast for Molecular Diagnostics Market by Hospitals & Academic Laboratories (Million US$), 2018 – 2024
Figure 7-3: Global - Molecular Diagnostics Market by Clinics and Commercial Laboratories (Million US$), 2011 – 2017
Figure 7-4: Global – Forecast for Molecular Diagnostics Market by Clinics and Commercial Laboratories (Million US$), 2018 – 2024
Figure 7-5: Global – Molecular Diagnostics Market by Others (Million US$), 2011 – 2017
Figure 7-6: Global – Forecast for Molecular Diagnostics Market by Others (Million US$), 2018 – 2024
Figure 8-1: Roche – Molecular Diagnostics Sales (Million US$), 2011 – 2017
Figure 8-2: Roche – Forecast for Molecular Diagnostics Sales (Million US$), 2018 – 2024
Figure 9-1: Abbott Laboratories– Molecular Diagnostics Sales (Million US$), 2011 – 2017
Figure 9-2: Abbott Laboratories – Forecast for Molecular Diagnostics Sales (Million US$), 2018 – 2024
Figure 10-1: Myriad Genetics –Molecular Diagnostics Sales (Million US$), 2011 – 2017
Figure 10-2: Myriad Genetics – Forecast for Molecular Diagnostics Sales (Million US$), 2018 – 2024
Figure 11-1: Qiagen –Molecular Diagnostics Sales (Million US$), 2011 – 2017
Figure 11-2: Qiagen – Forecast for Molecular Diagnostics Sales (Million US$), 2018 – 2024
Figure 12-1: bioMerieux –Molecular Diagnostics Sales (Million US$), 2011 – 2017
Figure 12-2: bioMerieux – Forecast for Molecular Diagnostics Sales (Million US$), 2018 – 2024